Subcutaneous DMPA: a better lower dose approach

Contraception. 2014 May;89(5):341-3. doi: 10.1016/j.contraception.2013.10.010. Epub 2013 Oct 26.

Authors

James D Shelton¹, Vera Halpern²

Affiliations

¹ Bureau for Global Health, U.S. Agency for International Development, Washington, DC 20523, USA. Electronic address: jshelton@usaid.gov.
² FHI 360, Research Triangle Park, NC 27709, USA.

PMID: 24267634
DOI: 10.1016/j.contraception.2013.10.010

No abstract available

MeSH terms

Contraceptive Agents, Female / administration & dosage*
Contraceptive Agents, Female / pharmacokinetics
Female
Humans
Injections, Subcutaneous
Medroxyprogesterone Acetate / administration & dosage*
Medroxyprogesterone Acetate / pharmacokinetics

Substances

Contraceptive Agents, Female
Medroxyprogesterone Acetate